Sodium valproate - Kowa

Drug Profile

Sodium valproate - Kowa

Alternative Names: K 828; K-828-AB; K-828-SP

Latest Information Update: 12 Oct 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Kowa
  • Class Antidementias; Antiepileptic drugs; Small molecules
  • Mechanism of Action 4-aminobutyrate transaminase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Spinal muscular atrophy
  • Discontinued Dementia

Most Recent Events

  • 12 Oct 2016 Chemical structure information added
  • 03 Oct 2016 Discontinued - Phase-II for Dementia in Japan (PO)
  • 30 Sep 2016 Phase-III clinical trials in Spinal muscular atrophy in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top